Crossmark

Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India

Crossref DOI link: https://doi.org/10.1186/s12936-020-03274-w

Published Online: 2020-08-14

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pathak, Ashish

Mårtensson, Andreas

Gawariker, Sudhir

Sharma, Ashish

Diwan, Vishal

Purohit, Manju

Ursing, Johan http://orcid.org/0000-0002-5508-9327
Funding

Funding for this research was provided by:

Stockholms Läns Landsting (20160597)
License Information

Text and Data Mining valid from 2020-08-14

Version of Record valid from 2020-08-14
More Information

Article History

Received: 16 January 2020

Accepted: 29 May 2020

First Online: 14 August 2020

Ethics approval and consent to participate

: Patients with uncomplicated malaria were enrolled and samples collected after informed oral consent of the patient or in the case of minors informed proxy-consent of their parent or guardian. The study was approved by the Institutional Ethics Committee of R D Gardi Medical College in Ujjain, Madhya Pradesh, India (61/2009 and 494/2016) and the Regional Ethics Committee in Stockholm, Sweden (2011/832-32/2).

: Not applicable.

: All authors: No reported competing interests.

Document is current

Any future updates will be listed below